These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 28182350)
1. Diagnostic Value of Serum hsa-mir-92a in Patients with Cervical Cancer. Kong Q; Tang Z; Xiang F; Jiang J; Yue H; Wu R; Kang X Clin Lab; 2017 Feb; 63(2):335-340. PubMed ID: 28182350 [TBL] [Abstract][Full Text] [Related]
2. Peripheral blood circulating microRNA-4636/-143 for the prognosis of cervical cancer. Yin S; Yang M; Li X; Zhang K; Tian J; Luo C; Bai R; Lu Y; Wang M J Cell Biochem; 2020 Jan; 121(1):596-608. PubMed ID: 31407404 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance of serum miR-196a in cervical intraepithelial neoplasia and cervical cancer. Liu P; Xin F; Ma CF Genet Mol Res; 2015 Dec; 14(4):17995-8002. PubMed ID: 26782446 [TBL] [Abstract][Full Text] [Related]
4. Study on serum miR-182 as a marker for diagnosis and prognosis of cervical cancer. Gao F; Wang Y; Li H; Yin J Technol Health Care; 2024; 32(5):3083-3095. PubMed ID: 38848201 [TBL] [Abstract][Full Text] [Related]
5. Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma. Chen J; Yao D; Li Y; Chen H; He C; Ding N; Lu Y; Ou T; Zhao S; Li L; Long F Int J Mol Med; 2013 Sep; 32(3):557-67. PubMed ID: 23799609 [TBL] [Abstract][Full Text] [Related]
6. Serum miR-92a-1 is a novel diagnostic biomarker for colorectal cancer. Shi Y; Liu Z J Cell Mol Med; 2020 Aug; 24(15):8363-8367. PubMed ID: 32562465 [TBL] [Abstract][Full Text] [Related]
7. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs. Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753 [TBL] [Abstract][Full Text] [Related]
8. Circulating miR-15b, miR-34a and miR-218 as promising novel early low-invasive biomarkers of cervical carcinogenesis. Ocadiz-Delgado R; Lizcano-Meneses S; Trejo-Vazquez JA; Conde-Perezprina JC; Garrido-Palmas F; Alvarez-Rios E; García-Villa E; Ruiz G; Illades-Aguiar B; Leyva-Vázquez MA; García-Carrancá A; Gariglio P APMIS; 2021 Feb; 129(2):70-79. PubMed ID: 33112434 [TBL] [Abstract][Full Text] [Related]
9. Enumeration of deregulated miRNAs in liquid and tissue biopsies of cervical cancer. Shukla V; Varghese VK; Kabekkodu SP; Mallya S; Chakrabarty S; Jayaram P; Pandey D; Banerjee S; Sharan K; Satyamoorthy K Gynecol Oncol; 2019 Oct; 155(1):135-143. PubMed ID: 31434614 [TBL] [Abstract][Full Text] [Related]
10. Exosomal let-7d-3p and miR-30d-5p as diagnostic biomarkers for non-invasive screening of cervical cancer and its precursors. Zheng M; Hou L; Ma Y; Zhou L; Wang F; Cheng B; Wang W; Lu B; Liu P; Lu W; Lu Y Mol Cancer; 2019 Apr; 18(1):76. PubMed ID: 30940131 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA Biomarkers of High-Grade Cervical Intraepithelial Neoplasia in Liquid Biopsy. Causin RL; da Silva LS; Evangelista AF; Leal LF; Souza KCB; Pessôa-Pereira D; Matsushita GM; Reis RM; Fregnani JHTG; Marques MMC Biomed Res Int; 2021; 2021():6650966. PubMed ID: 33954190 [TBL] [Abstract][Full Text] [Related]
12. Plasma miR-127 and miR-218 Might Serve as Potential Biomarkers for Cervical Cancer. You W; Wang Y; Zheng J Reprod Sci; 2015 Aug; 22(8):1037-41. PubMed ID: 25701838 [TBL] [Abstract][Full Text] [Related]
13. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer. Shi GL; Chen Y; Sun Y; Yin YJ; Song CX Clin Lab; 2017 Jan; 63(1):133-140. PubMed ID: 28164492 [TBL] [Abstract][Full Text] [Related]
14. Circulating and tissue miR-100 acts as a potential diagnostic biomarker for cervical cancer. Yamanaka Z; Sasaki T; Yamanaka A; Kato K; Nishi H Cancer Biomark; 2021; 32(4):551-558. PubMed ID: 34334379 [TBL] [Abstract][Full Text] [Related]
15. Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer. Rogeri CD; Silveira HCS; Causin RL; Villa LL; Stein MD; de Carvalho AC; Arantes LMRB; Scapulatempo-Neto C; Possati-Resende JC; Antoniazzi M; Longatto-Filho A; Fregnani JHTG Gynecol Oncol; 2018 Sep; 150(3):545-551. PubMed ID: 29960712 [TBL] [Abstract][Full Text] [Related]
16. A circulating serum miRNA panel as early detection biomarkers of cervical intraepithelial neoplasia. Xin F; Liu P; Ma CF Eur Rev Med Pharmacol Sci; 2016 Dec; 20(23):4846-4851. PubMed ID: 27981553 [TBL] [Abstract][Full Text] [Related]
17. Serum miR-3142 could be Used as a Potential Biomarker to Screen Cervical Cancer Patients from Healthy Controls. Luo Q; Wang H; Li J Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969093 [TBL] [Abstract][Full Text] [Related]
18. Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer. Zhao S; Yao D; Chen J; Ding N Genet Test Mol Biomarkers; 2013 Aug; 17(8):631-6. PubMed ID: 23819812 [TBL] [Abstract][Full Text] [Related]
19. Serum outperforms plasma in small extracellular vesicle microRNA biomarker studies of adenocarcinoma of the esophagus. Chiam K; Mayne GC; Wang T; Watson DI; Irvine TS; Bright T; Smith LT; Ball IA; Bowen JM; Keefe DM; Thompson SK; Hussey DJ World J Gastroenterol; 2020 May; 26(20):2570-2583. PubMed ID: 32523312 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA expression profile in serum reveals novel diagnostic biomarkers for endometrial cancer. Fan X; Zou X; Liu C; Cheng W; Zhang S; Geng X; Zhu W Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34076696 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]